These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7535183)

  • 21. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.
    Luckey CJ; King GM; Marto JA; Venketeswaran S; Maier BF; Crotzer VL; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH
    J Immunol; 1998 Jul; 161(1):112-21. PubMed ID: 9647214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of proline residue for efficient production of MHC class I ligands by proteasomes.
    Shimbara N; Ogawa K; Hidaka Y; Nakajima H; Yamasaki N; Niwa S; Tanahashi N; Tanaka K
    J Biol Chem; 1998 Sep; 273(36):23062-71. PubMed ID: 9722532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenicity and immunogenicity of an intracellular delivery system of major histocompatibility complex class I epitopes that bypasses proteasome processing.
    Tirosh B; Fridkin M; Tzehoval E; Vadai E; Lemonnier FA; Eisenbach L
    J Immunother; 2000; 23(6):622-30. PubMed ID: 11186150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of a specific major histocompatibility complex class I-restricted epitope by ubiquitin-dependent degradation of modified ovalbumin in lymphocyte lysate.
    Ben-Shahar S; Cassouto B; Novak L; Porgador A; Reiss Y
    J Biol Chem; 1997 Aug; 272(34):21060-6. PubMed ID: 9261108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presentation of a new H-2D(k)-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin.
    Lomas M; Hanon E; Tanaka Y; Bangham CRM; Gould KG
    J Gen Virol; 2002 Mar; 83(Pt 3):641-650. PubMed ID: 11842259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope.
    Theobald M; Ruppert T; Kuckelkorn U; Hernandez J; Häussler A; Ferreira EA; Liewer U; Biggs J; Levine AJ; Huber C; Koszinowski UH; Kloetzel PM; Sherman LA
    J Exp Med; 1998 Sep; 188(6):1017-28. PubMed ID: 9743520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The requirement for proteasome activity class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen.
    Yang B; Hahn YS; Hahn CS; Braciale TJ
    J Exp Med; 1996 Apr; 183(4):1545-52. PubMed ID: 8666912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues.
    Chen W; Khilko S; Fecondo J; Margulies DH; McCluskey J
    J Exp Med; 1994 Oct; 180(4):1471-83. PubMed ID: 7523572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation.
    López D; Del Val M
    J Immunol; 1997 Dec; 159(12):5769-72. PubMed ID: 9550370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope.
    Robertson JM; Jensen PE; Evavold BD
    J Immunol; 2000 May; 164(9):4706-12. PubMed ID: 10779776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the role of bleomycin hydrolase in antigen presentation and the generation of CD8 T cell responses.
    Towne CF; York IA; Watkin LB; Lazo JS; Rock KL
    J Immunol; 2007 Jun; 178(11):6923-30. PubMed ID: 17513741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathway.
    De Haan L; Hearn AR; Rivett AJ; Hirst TR
    Infect Immun; 2002 Jun; 70(6):3249-58. PubMed ID: 12011020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The RTP site shared by the HIV-1 Tat protein and the 11S regulator subunit alpha is crucial for their effects on proteasome function including antigen processing.
    Huang X; Seifert U; Salzmann U; Henklein P; Preissner R; Henke W; Sijts AJ; Kloetzel PM; Dubiel W
    J Mol Biol; 2002 Nov; 323(4):771-82. PubMed ID: 12419264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis.
    Kessler JH; Beekman NJ; Bres-Vloemans SA; Verdijk P; van Veelen PA; Kloosterman-Joosten AM; Vissers DC; ten Bosch GJ; Kester MG; Sijts A; Wouter Drijfhout J; Ossendorp F; Offringa R; Melief CJ
    J Exp Med; 2001 Jan; 193(1):73-88. PubMed ID: 11136822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of selective processing of immunodominant epitopes in virally infected cells.
    Zhang QJ; Chen SS; Saari CA; Massuci MG; Tufaro F; Jefferies WA
    J Immunol; 2000 May; 164(9):4513-21. PubMed ID: 10779752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: implications for vaccine design.
    Sijts A; Zaiss D; Kloetzel PM
    Curr Mol Med; 2001 Dec; 1(6):665-76. PubMed ID: 11899255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation.
    Ossendorp F; Eggers M; Neisig A; Ruppert T; Groettrup M; Sijts A; Mengedë E; Kloetzel PM; Neefjes J; Koszinowski U; Melief C
    Immunity; 1996 Aug; 5(2):115-24. PubMed ID: 8769475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The murine cytomegalovirus pp89 immunodominant H-2Ld epitope is generated and translocated into the endoplasmic reticulum as an 11-mer precursor peptide.
    Knuehl C; Spee P; Ruppert T; Kuckelkorn U; Henklein P; Neefjes J; Kloetzel PM
    J Immunol; 2001 Aug; 167(3):1515-21. PubMed ID: 11466372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of antigen-processing steps reveals preferences explaining differential biological outcomes of two HLA-A2-restricted immunodominant epitopes from human immunodeficiency virus type 1.
    Cohen WM; Bianco A; Connan F; Camoin L; Dalod M; Lauvau G; Ferriès E; Culmann-Penciolelli B; van Endert PM; Briand JP; Choppin J; Guillet JG
    J Virol; 2002 Oct; 76(20):10219-25. PubMed ID: 12239297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products.
    Toes RE; Nussbaum AK; Degermann S; Schirle M; Emmerich NP; Kraft M; Laplace C; Zwinderman A; Dick TP; Müller J; Schönfisch B; Schmid C; Fehling HJ; Stevanovic S; Rammensee HG; Schild H
    J Exp Med; 2001 Jul; 194(1):1-12. PubMed ID: 11435468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.